about
The plasminogen activator inhibitor-2 gene is not required for normal murine development or survivalMechanical stretch: physiological and pathological implications for human vascular endothelial cellsCrystal structure of the complex of plasminogen activator inhibitor 2 with a peptide mimicking the reactive center loopSystems Proteomics View of the Endogenous Human Claudin Protein FamilyOverexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascadeRecommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles)Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 2.1.De Novo Peptide Sequencing: Deep Mining of High-Resolution Mass Spectrometry Data.A Systematic Bioinformatics Approach to Identify High Quality Mass Spectrometry Data and Functionally Annotate Proteins and Proteomes.Homogeneous silver-coated nanoparticle substrates for enhanced fluorescence detection.Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery.The nuclear proteome and DNA-binding fraction of human Raji lymphoma cells.Comparing SILAC and two-dimensional gel electrophoresis image analysis for profiling urokinase plasminogen activator signaling in ovarian cancer cells.Identification and expression of a novel marsupial cathelicidin from the tammar wallaby (Macropus eugenii).Correlations between integrin ανβ6 expression and clinico-pathological features in stage B and stage C rectal cancer.Chromosome 7-centric analysis of proteomics data from a panel of human colon carcinoma cell lines.Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.Epithelial and stromal cell urokinase plasminogen activator receptor expression differentially correlates with survival in rectal cancer stages B and C patients.Multiphoton fluorescence lifetime imaging microscopy reveals free-to-bound NADH ratio changes associated with metabolic inhibition.Biorepository regulatory frameworks: building parallel resources that both promote scientific investigation and protect human subjects.Four areas of engagement requiring strengthening in modern proteomics today.A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers.Quest for Missing Proteins: Update 2015 on Chromosome-Centric Human Proteome Project.Combination of Multiple Spectral Libraries Improves the Current Search Methods Used to Identify Missing Proteins in the Chromosome-Centric Human Proteome Project.The Asia Oceania Human Proteome Organisation Membrane Proteomics Initiative. Preparation and characterisation of the carbonate-washed membrane standardAccelerating the search for the missing proteins in the human proteome.Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor.Clinical proteomics stretch goals: EuPA 2012 roundtable report.Recent findings from the Human Proteome Project: opening the mass spectrometry toolbox to advance cancer diagnosis, surveillance and treatment.Protannotator: a semiautomated pipeline for chromosome-wise functional annotation of the "missing" human proteome.Is isolation of comprehensive human plasma peptidomes an achievable quest?Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry.Improved membrane proteomics coverage of human embryonic stem cells by peptide IPG-IEF.Integrin αvβ6 sets the stage for colorectal cancer metastasis.Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers.Characterization of the interaction between heterodimeric αvβ6 integrin and urokinase plasminogen activator receptor (uPAR) using functional proteomics.Proteomics of Huntington's disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances.Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines.Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy.
P50
Q24554422-70FA9294-28CB-45AA-A831-B4174FD3ECE8Q26782873-EE1DEE36-2D10-46A2-9D97-35906D63092EQ27634754-65C1A3FE-2AC3-4155-A240-AFBFE9892BD7Q28271194-7995BDF0-058E-4E76-B6A0-AF4BA402670AQ28610889-AF90BF9A-17E9-4172-9D1D-E6DB779E18FCQ30485191-1DFDE4BA-48DB-4B57-B2A9-5B6CB798650BQ31119582-159F9691-241C-4AF0-A1F1-B31920BB3762Q31148965-E497D356-E404-4D8D-A4BD-371D6366CC6CQ31148970-7EFF8332-4532-4A08-9081-3D526094B00AQ33263660-39788668-1209-4931-9D30-B7A90ABB4B94Q33271404-38102CFD-1920-4DD0-BEEC-22FEE24737DFQ33279260-8F0D5BF1-83D4-4A2D-A056-3BB291A8DEACQ33283336-6F2E2798-8687-4714-A8C5-40D2E565FBC0Q33388596-C799AD4D-12ED-484A-AFB2-6B2B05D93C27Q33599336-65A7BC30-A279-438E-B1AE-9B7B4CD4611DQ34514050-A6889B90-EC08-45B2-BA93-FCF9A3CFC767Q34669490-682E74A0-D039-41C2-8657-2B3109B9FDBAQ35097486-831DCE8D-E5FF-4E67-9115-EC2654AAF6CCQ35228615-514AE093-771D-4BE1-9FB5-3EF17264E157Q35296631-B96A731F-3912-4BAA-849D-A4A592B5BBDFQ35432254-D0CE9216-C48A-4DC4-845E-4152843FCCA4Q35619009-1A5C9544-8E1E-4715-BA2A-40CB99C661CCQ35663974-A3CD6D5A-233A-4E08-A528-74550B20D024Q35761755-93936B0A-ADC1-47DA-A8E2-5D8920BFCE60Q37479376-A1911585-2F86-45F7-9D92-FC6C5C40D2B9Q37617923-09520D8B-307A-4808-8A7A-4E6AC1D96712Q37694940-A9C62B71-7648-4B88-8489-5DECA2CA7551Q38099968-D71A9B82-E223-4267-9B11-D1304BA32A24Q38449763-A8D4C571-DB87-45CE-A7AC-4056F5C3EB2EQ38482345-6DE8E82A-1B21-441B-AA79-813FB92AF68AQ38483927-6B781037-DBEC-4CCC-A59C-2C2A052A416CQ38501253-F184B44E-03C2-48F6-9999-25DA53F40D49Q38508416-F720C317-80E4-43C5-9F55-4E8002F39657Q38580357-7233B741-7559-4E11-AC7F-D91E6C6CFC86Q38764225-9EF3554F-B2F3-4717-ADE7-CAF743051D0DQ38947629-BCF28E34-39CF-4C5F-B94E-30CA259DC72CQ38947785-27AA4289-FEB3-49DC-A478-9DF3E371FF8BQ39051308-A9475D71-010B-4D75-8A63-5B219CA23897Q39937267-42C68309-F52C-4B85-A153-FF87E4850DA5Q40165011-336BCF2E-8CC2-4275-B2A8-C1B648356DBF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mark Baker
@ast
Mark Baker
@en
Mark Baker
@es
Mark Baker
@nl
Mark Baker
@sl
Марк Бейкер
@ru
馬克·貝克
@zh-hant
type
label
Mark Baker
@ast
Mark Baker
@en
Mark Baker
@es
Mark Baker
@nl
Mark Baker
@sl
Марк Бейкер
@ru
馬克·貝克
@zh-hant
prefLabel
Mark Baker
@ast
Mark Baker
@en
Mark Baker
@es
Mark Baker
@nl
Mark Baker
@sl
Марк Бейкер
@ru
馬克·貝克
@zh-hant
P106
P1153
35513691600
P21
P31
P496
0000-0001-5858-4035